Cachet Pharmaceutical Co., Ltd. (002462.SZ)
CNY 12.49
(0.4%)
CNY 12.49
(0.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.13 Billion CNY | -45.86% |
| 2022 | 2.09 Billion CNY | 25.67% |
| 2021 | 1.66 Billion CNY | -5.38% |
| 2020 | 1.76 Billion CNY | -6.69% |
| 2019 | 1.88 Billion CNY | -16.11% |
| 2018 | 2.24 Billion CNY | 33.04% |
| 2017 | 1.69 Billion CNY | 87.7% |
| 2016 | 900.56 Million CNY | -6.75% |
| 2015 | 965.77 Million CNY | 59.39% |
| 2014 | 605.9 Million CNY | 418.23% |
| 2013 | -190.39 Million CNY | 49.15% |
| 2012 | -374.41 Million CNY | 27.0% |
| 2011 | -512.92 Million CNY | -10.19% |
| 2010 | -465.5 Million CNY | -206.47% |
| 2009 | -151.89 Million CNY | -34.24% |
| 2008 | -113.14 Million CNY | -902.02% |
| 2007 | -11.29 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 457.77 Million CNY | -59.6% |
| 2024 Q3 | 626.77 Million CNY | -40.79% |
| 2024 Q2 | 1.34 Billion CNY | 193.53% |
| 2023 Q4 | 1.13 Billion CNY | -13.5% |
| 2023 Q2 | 1.46 Billion CNY | -4.07% |
| 2023 FY | 1.13 Billion CNY | -45.86% |
| 2023 Q3 | 1.31 Billion CNY | -10.84% |
| 2023 Q1 | 1.53 Billion CNY | -26.83% |
| 2022 Q2 | 3 Billion CNY | 27.37% |
| 2022 Q3 | 2.59 Billion CNY | -13.4% |
| 2022 FY | 2.09 Billion CNY | 25.67% |
| 2022 Q4 | 2.09 Billion CNY | -19.47% |
| 2022 Q1 | 2.35 Billion CNY | 41.49% |
| 2021 Q3 | 2.07 Billion CNY | -0.46% |
| 2021 Q4 | 1.66 Billion CNY | -19.87% |
| 2021 Q1 | 1.71 Billion CNY | -2.68% |
| 2021 FY | 1.66 Billion CNY | -5.38% |
| 2021 Q2 | 2.08 Billion CNY | 21.89% |
| 2020 Q3 | 2.35 Billion CNY | 14.99% |
| 2020 Q1 | 2.24 Billion CNY | 19.03% |
| 2020 Q4 | 1.76 Billion CNY | -25.33% |
| 2020 Q2 | 2.05 Billion CNY | -8.71% |
| 2020 FY | 1.76 Billion CNY | -6.69% |
| 2019 Q3 | 1.87 Billion CNY | -25.32% |
| 2019 Q1 | 2.29 Billion CNY | 2.22% |
| 2019 Q4 | 1.88 Billion CNY | 0.86% |
| 2019 FY | 1.88 Billion CNY | -16.11% |
| 2019 Q2 | 2.5 Billion CNY | 8.94% |
| 2018 Q2 | 2.18 Billion CNY | -0.39% |
| 2018 Q1 | 2.19 Billion CNY | 29.6% |
| 2018 FY | 2.24 Billion CNY | 33.04% |
| 2018 Q3 | 2.37 Billion CNY | 9.06% |
| 2018 Q4 | 2.24 Billion CNY | -5.5% |
| 2017 Q2 | 1.37 Billion CNY | 22.31% |
| 2017 FY | 1.69 Billion CNY | 87.7% |
| 2017 Q4 | 1.69 Billion CNY | 96.65% |
| 2017 Q3 | 859.56 Million CNY | -37.31% |
| 2017 Q1 | 1.12 Billion CNY | 24.48% |
| 2016 Q4 | 900.56 Million CNY | -5.32% |
| 2016 Q1 | 888.34 Million CNY | -8.02% |
| 2016 Q2 | 888.08 Million CNY | -0.03% |
| 2016 FY | 900.56 Million CNY | -6.75% |
| 2016 Q3 | 951.2 Million CNY | 7.11% |
| 2015 Q3 | 1.1 Billion CNY | 10.88% |
| 2015 FY | 965.77 Million CNY | 59.39% |
| 2015 Q1 | 691.85 Million CNY | 14.19% |
| 2015 Q4 | 965.77 Million CNY | -12.51% |
| 2015 Q2 | 995.51 Million CNY | 43.89% |
| 2014 Q1 | -292.27 Million CNY | -53.51% |
| 2014 FY | 605.9 Million CNY | 418.23% |
| 2014 Q4 | 605.9 Million CNY | 251.43% |
| 2014 Q3 | 172.41 Million CNY | 246.07% |
| 2014 Q2 | -118.03 Million CNY | 59.62% |
| 2013 FY | -190.39 Million CNY | 49.15% |
| 2013 Q2 | -363.09 Million CNY | -0.71% |
| 2013 Q3 | -379.95 Million CNY | -4.64% |
| 2013 Q1 | -360.54 Million CNY | 3.71% |
| 2013 Q4 | -190.39 Million CNY | 49.89% |
| 2012 Q3 | -324.55 Million CNY | 26.65% |
| 2012 Q1 | -459.39 Million CNY | 10.44% |
| 2012 Q2 | -442.45 Million CNY | 3.69% |
| 2012 Q4 | -374.41 Million CNY | -15.36% |
| 2012 FY | -374.41 Million CNY | 27.0% |
| 2011 Q3 | -362.59 Million CNY | 22.0% |
| 2011 FY | -512.92 Million CNY | -10.19% |
| 2011 Q4 | -512.92 Million CNY | -41.46% |
| 2011 Q1 | -311.59 Million CNY | 33.06% |
| 2011 Q2 | -464.84 Million CNY | -49.18% |
| 2010 FY | -465.5 Million CNY | -206.47% |
| 2010 Q4 | -465.5 Million CNY | 8.51% |
| 2010 Q3 | -508.83 Million CNY | -296.0% |
| 2010 Q2 | -128.49 Million CNY | 0.0% |
| 2009 FY | -151.89 Million CNY | -34.24% |
| 2009 Q4 | -151.89 Million CNY | 0.0% |
| 2008 FY | -113.14 Million CNY | -902.02% |
| 2007 FY | -11.29 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Yixintang Pharmaceutical Group Co., Ltd. | 1.21 Billion CNY | 6.382% |
| ZJAMP Group Co., Ltd. | -2.65 Billion CNY | 142.722% |
| Luyan Pharma Co.,Ltd. | 4.23 Billion CNY | 73.235% |
| Ji Yao Holding Group Co., Ltd. | 1.42 Billion CNY | 20.244% |